Firms
Theme

EXC

Exelon Corporation · NASDAQ

News

7 latest

Zacks Investment Research

Exelon (EXC) Expected to Beat Earnings Estimates: Should You Buy?

Exelon (EXC) is positioned as a compelling earnings-beat candidate for Q3 2026 with a +3.73% Earnings ESP and Zacks Rank #3, suggesting it will likely beat consensus EPS estimates of $0.81. Meanwhile, IdaCorp (IDA) presents a more uncertain outlook with a -0.53% Earnings ESP despite a Zacks Rank #3, making it difficult to predict whether it will beat its $2.51 EPS estimate.

Zacks Investment Research

Are You Looking for a High-Growth Dividend Stock?

Exelon (EXC), a Chicago-based utility company, is highlighted as a strong dividend play for income investors. The stock offers a 3.94% dividend yield, above the industry average of 3.18%, with an annualized dividend of $1.68 up 5% year-over-year.

Zacks Investment Research

Top Research Reports for Mastercard, AstraZeneca & Sandisk

Zacks analysts published research on 16 major stocks on October 14, 2026. Mastercard received a Neutral rating despite strong performance, citing competitive pricing pressure and premium valuation concerns.

Zacks Investment Research

EXC vs. ES: Which Utility Stock Offers Better Investment Potential?

Exelon Corporation (EXC) and Eversource Energy (ES) are compared as both utilities invest heavily in grid infrastructure to meet rising electricity demand from data centers and industrial reshoring. Exelon is identified as the preferred pick due to stronger earnings growth projections (6.39% long-term), a larger capital investment plan ($41.7 billion through 2029), better debt position, and superior recent price performance. Eversource offers a higher dividend yield (4.83% vs. 4.05%) but faces headwinds with lower earnings growth and higher debt-to-capital ratio.

The Motley Fool

Could Buying Constellation Energy Today Set You Up for Life?

Constellation Energy, spun off from Exelon in February 2022, has grown from $50.04 to $255 per share. The independent power producer benefits from AI and cloud computing demand, operates the largest U.S. nuclear fleet (22 GW of 55 GW total capacity), and serves 80% of Fortune 100 companies. With expected 31% EPS CAGR from 2025-2028 and a reasonable valuation at 20x next year's earnings, analysts view it as a strong long-term hold for investors betting on rising global electricity demand.

Mentions EXC

Zacks Investment Research

NextEra Energy Q3 Earnings Beat on FPL Strength, Revenues Miss

NextEra Energy (NEE) reported Q3 adjusted EPS of $1.24, beating consensus estimates by 3.3%, driven by strong performance from Florida Power & Light and NextEra Energy Resources. The company added 3.7 GW to its renewables backlog and maintained its 2026 EPS guidance of $3.92-$4.02.

Zacks Investment Research

PPL Stock Posts Smaller Three-Month Loss Than Industry: How to Play?

PPL Corporation plans $23 billion in capital spending through 2029 targeting 6-8% annual earnings growth, supported by strong data center demand in Pennsylvania (31.8 GW) and Kentucky (13.7 GW pipeline). The company targets $175M in O&M savings by 2026 and 6-8% annual dividend growth through 2028. Despite trading at a premium valuation (P/E 15.83X vs industry 13.63X), PPL's lower debt-to-capital ratio (57.46%), rising earnings estimates, and consistent shareholder returns make it an attractive entry point following recent 9.2% share price decline.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $EXC · 0 threads

Sign in to post on $EXC

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev